Explore the benefits of adopting universal molecular genetic testing for newborn screening of haemoglobinopathies to improve ...
Bio-Techne's Asuragen brand inks a partnership with Oxford Nanopore Technologies to launch research-use-only AmplideX Nanopore Carrier Plus Kit.
The kit targets genes like CFTR, CYP21A2, F8 inversions, FMR1, GBA, HBA1, HBA2, HBB, SMN1, SMN2 and TNXB. Per a report by TechSci Research, the global Nanopore Sequencing market was valued at $330 ...
AmplideX ® Nanopore Carrier Plus Kit uses nanopore sequencing to resolve high-prevalence genes. MINNEAPOLIS and OXFORD, England, March 3, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback